Your browser doesn't support javascript.
loading
Exome sequencing reveals predominantly de novo variants in disorders with intellectual disability (ID) in the founder population of Finland.
Järvelä, Irma; Määttä, Tuomo; Acharya, Anushree; Leppälä, Juha; Jhangiani, Shalini N; Arvio, Maria; Siren, Auli; Kankuri-Tammilehto, Minna; Kokkonen, Hannaleena; Palomäki, Maarit; Varilo, Teppo; Fang, Mary; Hadley, Trevor D; Jolly, Angad; Linnankivi, Tarja; Paetau, Ritva; Saarela, Anni; Kälviäinen, Reetta; Olme, Jan; Nouel-Saied, Liz M; Cornejo-Sanchez, Diana M; Llaci, Lorida; Lupski, James R; Posey, Jennifer E; Leal, Suzanne M; Schrauwen, Isabelle.
Afiliação
  • Järvelä I; Department of Medical Genetics, University of Helsinki, P.O. Box 720, 00251, Helsinki, Finland. irma.jarvela@helsinki.fi.
  • Määttä T; Disability Services, Joint Authority for Kainuu, Kajaani, Finland.
  • Acharya A; Center for Statistical Genetics, Sergievsky Center, Taub Institute for Alzheimer's Disease and the Aging Brain, and the Department of Neurology, Columbia University Medical Center, New York, NY, USA.
  • Leppälä J; Eskoo The Center for Disability Empowerment, Seinäjoki, Finland.
  • Jhangiani SN; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, 77030, USA.
  • Arvio M; KTO-Special Welfare District of Varsinais-Suomi, Paimio, Finland.
  • Siren A; Päijät-Häme Joint Municipal Authority, Lahti, Finland.
  • Kankuri-Tammilehto M; PEDEGO, University of Oulu, Oulu, Finland.
  • Kokkonen H; Department of Clinical Genetics, Turku University Hospital, Turku, Finland.
  • Palomäki M; Kanta-Häme Central Hospital, Hämeenlinna, Finland.
  • Varilo T; Department of Clinical Genetics, Turku University Hospital, Turku, Finland.
  • Fang M; Department of Clinical Genetics, University of Turku, Turku, Finland.
  • Hadley TD; Northern Finland Laboratory Centre NordLab and Medical Research Centre, Oulu University Hospital and University of Oulu, Oulu, Finland.
  • Jolly A; Department of Radiology, Helsinki University Hospital, Helsinki, Finland.
  • Linnankivi T; Department of Medical Genetics, University of Helsinki, P.O. Box 720, 00251, Helsinki, Finland.
  • Paetau R; Baylor College of Medicine, Houston, TX, 77030, USA.
  • Saarela A; Baylor College of Medicine, Houston, TX, 77030, USA.
  • Kälviäinen R; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
  • Olme J; Department of Child Neurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Nouel-Saied LM; Department of Child Neurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Cornejo-Sanchez DM; Institute of Clinical Medicine, School of Medicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland.
  • Llaci L; Kuopio Epilepsy Center, Kuopio University Hospital, Neurocenter, Finland.
  • Lupski JR; Institute of Clinical Medicine, School of Medicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland.
  • Posey JE; Kuopio Epilepsy Center, Kuopio University Hospital, Neurocenter, Finland.
  • Leal SM; Department of Child Neurology, Vaasa Central Hospital, Vaasa, Finland.
  • Schrauwen I; Center for Statistical Genetics, Sergievsky Center, Taub Institute for Alzheimer's Disease and the Aging Brain, and the Department of Neurology, Columbia University Medical Center, New York, NY, USA.
Hum Genet ; 140(7): 1011-1029, 2021 Jul.
Article em En | MEDLINE | ID: mdl-33710394
ABSTRACT
The genetics of autosomal recessive intellectual disability (ARID) has mainly been studied in consanguineous families, however, founder populations may also be of interest to study intellectual disability (ID) and the contribution of ARID. Here, we used a genotype-driven approach to study the genetic landscape of ID in the founder population of Finland. A total of 39 families with syndromic and non-syndromic ID were analyzed using exome sequencing, which revealed a variant in a known ID gene in 27 families. Notably, 75% of these variants in known ID genes were de novo or suspected de novo (64% autosomal dominant; 11% X-linked) and 25% were inherited (14% autosomal recessive; 7% X-linked; and 4% autosomal dominant). A dual molecular diagnosis was suggested in two families (5%). Via additional analysis and molecular testing, we identified three cases with an abnormal molecular karyotype, including chr21q22.12q22.2 uniparental disomy with a mosaic interstitial 2.7 Mb deletion covering DYRK1A and KCNJ6. Overall, a pathogenic or likely pathogenic variant was identified in 64% (25/39) of the families. Last, we report an alternate inheritance model for 3 known ID genes (UBA7, DDX47, DHX58) and discuss potential candidate genes for ID, including SYPL1 and ERGIC3 with homozygous founder variants and de novo variants in POLR2F and DNAH3. In summary, similar to other European populations, de novo variants were the most common variants underlying ID in the studied Finnish population, with limited contribution of ARID to ID etiology, though mainly driven by founder and potential founder variation in the latter case.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Exoma / Deficiência Intelectual Limite: Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Hum Genet Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Finlândia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Exoma / Deficiência Intelectual Limite: Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Hum Genet Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Finlândia